Cargando…
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice
Intranasal vaccination using influenza vectors is a promising approach to developing vaccines against respiratory pathogens due to the activation of the mucosa-associated immune response. However, there is no clear evidence of a vector design that could be considered preferable. To find the optimal...
Autores principales: | Pulkina, Anastasia, Vasilyev, Kirill, Muzhikyan, Arman, Sergeeva, Mariia, Romanovskaya-Romanko, Ekaterina, Shurygina, Anna-Polina, Shuklina, Marina, Vasin, Andrey, Stukova, Marina, Egorov, Andrej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380829/ https://www.ncbi.nlm.nih.gov/pubmed/37511205 http://dx.doi.org/10.3390/ijms241411445 |
Ejemplares similares
-
Enhancement of the Local CD8(+) T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens
por: Vasilyev, Kirill, et al.
Publicado: (2021) -
Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against Mycobacterium tuberculosis in Mice and Guinea Pigs
por: Sergeeva, Mariia, et al.
Publicado: (2021) -
Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs
por: Vasilyev, Kirill, et al.
Publicado: (2021) -
Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter
por: Sergeeva, M. V., et al.
Publicado: (2022) -
IFN-λ1 Displays Various Levels of Antiviral Activity In Vitro in a Select Panel of RNA Viruses
por: Plotnikova, Marina, et al.
Publicado: (2021)